Open PA-07-300 CFDA 93.838 Discretionary

Hypersensitivity Pneumonitis - Early Identification and Mechanisms of Disease (R01)

Posted by National Institutes of Health

Opportunity snapshot. This Grants.gov announcement — Hypersensitivity Pneumonitis - Early Identification and Mechanisms of Disease (R01) — is cataloged under number PA-07-300 and tied to CFDA assistance listing 93.838, posted by National Institutes of Health. Grants.gov currently shows the opportunity as open, first posted on January 17, 2007 and last updated on December 5, 2008. The funding category is Discretionary, delivered as a grant.

Award economics. The award range on file is Varies by applicant. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.

Deadline and action path. This opportunity is open, but Grants.gov has not published a hard closing date — check the official listing for the current deadline and any posted amendments. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully — federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed — it helps clarify scope and scoring priorities.

Award Range

Varies by applicant

Close Date

Not specified

Multiple Receipt Dates - See Link to Full Announcement for details.

Posted

January 17, 2007

Instrument

Grant

Description

-Purpose. To address the importance of continued research about forms of Hypersensitivity Pneumonitis Lung Diseases, especially the early recognition of disease and a better understanding of immune mechanisms involved in the cause and pathogenesis. -Mechanism of Support. This FOA will utilize the R01 mechanism. This R01 mechanism will support different types of projects including pilot and feasibility studies; small, self-contained research projects; and development of new research technology. -Eligible Institutions/Organizations. Public/State Controlled Institution of Higher Education; Private Institution of Higher Education; Nonprofit with 501(c)(3) IRS Status (Other than Institution of Higher Education); Nonprofit without 501(c)(3) IRS Status (Other than Institution of Higher Education); Small Business; For-Profit Organization (Other than Small Business); State Government; U.S. Territory or Possession; Indian/Native American Tribal Government (Federally Recognized); Indian/Native American Tribal Government (Other than Federally Recognized); Indian/Native American Tribally Designated Organization; Non-domestic (non-U.S.) Entity (Foreign Organization); Hispanic-serving Institution; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); Alaska Native and Native Hawaiian Serving Institutions; Regional Organization; Other(s): Eligible agencies of the Federal government; Faith-based or community based organizations.

Eligibility

00;01;02;04;05;06;07;08;11;12;13;20;22;23;25

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Parent Grant Program

CFDA 93.838

Lung Disease Research

National Institutes of Health

View program →

Agency Contact

NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>

Key Dates

Posted January 17, 2007
Close Date Not specified
Archive Date December 6, 2009
Last Updated December 5, 2008

Frequently Asked Questions

What is this grant opportunity?
This is a federal funding opportunity titled "Hypersensitivity Pneumonitis - Early Identification and Mechanisms of Disease (R01)", offered by National Institutes of Health. It is associated with CFDA program 93.838. -Purpose. To address the importance of continued research about forms of Hypersensitivity Pneumonitis Lung Diseases, especially the early recognition of disease and a better understanding of immune me...
Is this opportunity still open?
Yes, this opportunity is currently open for applications.
How much funding is available?
The award range for this opportunity is Varies by applicant.
How do I apply?
Applications for federal grant opportunities are typically submitted through Grants.gov. Visit the official listing at grants.gov for application instructions, required documents, and submission deadlines.

More from National Institutes of Health

Open Closes November 2, 2028

Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)

View →
Open Closes November 2, 2028

Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)

View →
Open Closes November 2, 2028

Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)

View →
Open Closes January 25, 2028

Development of Collaborative Research Facilities or Research-Resource Facilities (C06 Clinical Trial Not Allowed)

View →
Open Closes March 5, 2029

Research Grants in Clinical Informatics (R01 Clinical Trial Optional)

View →

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Read our methodology — how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainGrants Editorial